The Journal of Allergy and Clinical Immunology
Volume 122, Issue 1 , Pages 36-41 , July 2008

Advances in basic and clinical immunology in 2007

  • Javier Chinen, MD, PhD

      Affiliations

    • Corresponding Author InformationReprint requests: Javier Chinen, MD, PhD, Department of Pediatrics, Allergy and Immunology Section, Baylor College of Medicine, 6621 Fannin St FC 330.01, Houston, TX 77030.
    • ,
  • William T. Shearer, MD, PhD

Received 23 April 2008 ,Accepted 25 April 2008.

References 

  1. Koya T, Matsuda H, Takeda K, Matsubara S, Miyahara N, Balhorn A, et al. IL-10 treated IL-10–treated dendritic cells decrease airway hyperresponsiveness and airway inflammation in mice. J Allergy Clin Immunol. 2007;119:1241–1250
  2. Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B, Ebner C. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance and immune deviation. J Allergy Clin Immunol. 2007;120:707–713
  3. Triggiani M, Petraroli A, Loffredo S, Frattini A, Granata F, Morabito P, et al. Differentiation of monocytes into macrophages induces the upregulation of histamine. J Allergy Clin Immunol. 2007;119:472–481
  4. Ebner S, Nguyen VA, Forstner M, Wang YH, Wolfram D, Liu YJ, et al. Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen-presenting cells that induce proallergic T cells. J Allergy Clin Immunol. 2007;119:982–990
  5. Hsu SC, Tsai TH, Kawasaki H, Chen CH, Plunkett B, Lee RT, et al. Antigen coupled with Lewis-x trisaccharides elicits potent immune responses in mice. J Allergy Clin Immunol. 2007;119:1522–1528
  6. Kinnunen T, Jutila K, Kwok WW, Rytkonen-Nissinen M, Immonen A, Saarelainen S, et al. Potential of an altered peptide ligand of lipocalin allergen Bos D 2 for peptide immunotherapy. J Allergy Clin Immunol. 2007;119:965–972
  7. Ando T, Hatsuhika K, Wako M, Ohba T, Koyama K, Ohnuma Y, et al. Orally administered TGF-b is biologically active in the intestinal mucosa and enhances oral tolerance. J Allergy Clin Immunol. 2007;120:916–923
  8. Takhar P, Corrigan CJ, Smurthwaite L, O'Connor BJ, Durham SR, Lee TH, et al. Class-switch recombination to IgE in the bronchial mucosa of atopic and non-atopic patients with asthma. J Allergy Clin Immunol. 2007;119:213–218
  9. Persson H, Sadegh MK, Greiff L, Ohlin M. Delineating the specificity of an IgE-encoding transcriptome. J Allergy Clin Immunol. 2007;120:1186–1192
  10. Lim A, Luderschmidt S, Weidinger A, Schnopp C, Ring J, Hein R, et al. The IgE repertoire in PBMCs of atopic patients is characterized by individual rearrangements without variable region of the heavy immunoglobulin chain bias. J Allergy Clin Immunol. 2007;120:696–706
  11. Soeria-Atmadja D, Onell A, Kober A, Matsson P, Guftafsson MG, Hammerling U. Multivariate statistical analysis of large-scale IgE antibody measurements reveals allergen extract relationships in sensitized individuals. J Allergy Clin Immunol. 2007;120:1433–1440
  12. Fawaz LM, Sharif-Askari E, Hajoui O, Soussi-Gounni A, Hamid Q, Mazer BD. Expression of IL-9 receptor alpha chain on human germinal center B cells modulates IgE secretion. J Allergy Clin Immunol. 2007;120:1208–1215
  13. Hajoui O, Zheng H, Guay J, Letuve S, Fawaz LM, Mazer BD. Regulation of IL-13 receptor alpha1 expression and signaling on human tonsillar B-lymphocyte subsets. J Allergy Clin Immunol. 2007;120:1425–1432
  14. Klunker S, Saggar LR, Seyfert-Margolis V, Asare AL, Casale TB, Durham SR, et al. Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: inhibition of IgE-facilitated allergen binding. J Allergy Clin Immunol. 2007;120:688–695
  15. Sands MF, Blume JW, Schwartz SA. Successful treatment of 3 patients with recurrent idiopathic angioedema with omalizumab. J Allergy Clin Immunol. 2007;120:979–981
  16. Allen LC, Cl Kepley, Saxon A, Zhang K. Modifications of the Fcγ-Fcɛ fusion protein alters its effectiveness in the inhibition of FcɛRI-mediated functions. J Allergy Clin Immunol. 2007;120:462–468
  17. Yoshioka M, Fukuishi N, Iriguchi S, Ohsaki K, Yamanobe H, Inukai A, et al. Lipoteichoic acid downregulates FcɛRI expression on human mast cells through Toll-like receptor 2. J Allergy Clin Immunol. 2007;120:452–461
  18. Jartti T, Burmeister KA, Seroogy CM, Jennens-Clough M, Tisler CJ, Salazar LP, et al. Association between CD4+CD25+ T cells and atopy in children. J Allergy Clin Immunol. 2007;120:177–183
  19. Hartl D, Koller B, Melhorn AT, Reinhardt D, NIcolai T, Schendel DJ, et al. Quantitative and functional impairment of pulmonary CD4+CD25+ regulatory T cell in pediatric asthma. J Allergy Clin Immunol. 2007;119:1258–1266
  20. Orihara K, Narita M, Tobe T, Akasawa A, Ohya Y, Matsumoto K, et al. Circulating FoxP3+CD4+ cell numbers in atopic patients and healthy control subjects. J Allergy Clin Immunol. 2007;120:960–962
  21. Maggi L, Sanatrlasci V, Liotta F, Frosali F, Angeli R, Cosmi L, et al. Demonstration of circulating allergen-specific CD4+CD25+Foxp3+ T-regulatory cells in both nonatopic and atopic individuals. J Allergy Clin Immunol. 2007;120:429–436
  22. Romagnani S. Coming back to a missing immune deviation as the main explanatory mechanism for the hygiene hypothesis. J Allergy Clin Immunol. 2007;119:1511–1513
  23. Rothers J, Stren DA, Spangenberg A, Lohman IC, Halonen M, Wright AL. Influence of early day-care exposure on total IgE levels through age 3 years. J Allergy Clin Immunol. 2007;120:1201–1207
  24. Janson C, Asbjornsdottir H, Birgisdottir A, Sirgurjonsdottir RB, Gunnbjornsdottir M, Gislalon D, et al. The effect of infectious burden on the prevalence of atopy and respiratory allergies in Iceland, Estonia and Sweden. J Allergy Clin Immunol. 2007;120:673–679
  25. Debarry J, Garn H, Hanuszkiewicz A, Dickgreber N, Blumer N, von Mutius E, et al. Acinetobacter lwoffii and Lactococcus lactis strains isolated from farm cowshed possess strong allergy-protective properties. J Allergy Clin Immunol. 2007;119:1514–1521
  26. Smits HH, Hammad H, van Nimwegen M, Souille T, Willart MA, Lievers E, et al. Protective effect of Schistosoma mansoni infection on allergic airway inflammation depend son the intensity and chronicity of infection. J Allergy Clin Immunol. 2007;120:932–940
  27. Bree A, Schlerman FJ, Wadanoll M, Tchistiakova L, Marquette K, Tan XY, et al. IL-13 blockade reduces lung inflammation after Ascaris suum challenge in cynomolgus monkeys. J Allergy Clin Immunol. 2007;119:1251–1257
  28. Wang L, Joad JP, Abel K, Spinner A, Smiley-Jewel S, Liu H, et al. Effects of environmental tobacco smoke on the developing immune system of infant monkeys. J Allergy Clin Immunol. 2007;120:445–451
  29. Williams MA, Porter M, Horton M, Guo J, Roman J, Williams A, et al. Ambient particulate matter directs nonclassic dendritic cell activation and a mixed Th1/TH2 like cytokine response by naïve CD4+ T cells. J Allergy Clin Immunol. 2007;119:488–497
  30. Kim HJ, Barajas B, Chan RC, Nel AE. Glutathione depletion inhibits dendritic cell maturation and delayed-type hypersensitivity: implications for systemic disease and immunosenescence. J Allergy Clin Immunol. 2007;119:1225–1233
  31. Gernez Y, Tirounvanziam R, Nguyen KD, Herzenberg LA, Krensky AM, Nadeau KC. Altered phosphorylated signal transducer and activator of transcription profile of CD4+CD161+ T cells in asthma: modulation by allergic status and oral corticosteroids. J Allergy Clin Immunol. 2007;120:1441–1448
  32. Mutalithas K, Croudace J, Guille C, Sidiqui S, Thicket D, Wardlaw A, et al. Bronchoalveolar lavage invariant natural killer T cells are not increased in asthma. J Allergy Clin Immunol. 2007;119:1274–1276
  33. Palmer BE, Mack DG, Martin AK, Maier LA, Fontenot AP. CD57 expression correlates with alveolitis severity in subjects with beryllium-induced disease. J Allergy Clin Immunol. 2007;120:184–191
  34. Prasse A, Germann M, Pechkovsky DV, Markert A, Verres T, Stahl M, et al. IL-10-producing monocytes differentiate to alternatively activated macrophages and are increased in atopic patients. J Allergy Clin Immunol. 2007;119:464–471
  35. Knitz J, Rothman PB. Suppressor of cytokine signaling in allergic inflammation. J Allergy Clin Immunol. 2007;119:739–745
  36. Wells JW, Cowled CJ, Giorgini A, Kennedy DM, Noble A. Regulation of allergic airway inflammation by class I–restricted allergen presentation and CD8 T-cell infiltration. J Allergy Clin Immunol. 2007;119:226–234
  37. Palmer CN, Ismail T, Lee SP, Terron-Kwiatkowski A, Zhao Y, Liao H, et al. Filaggrin null mutations are associated with increased asthma severity in children and young adults. J Allergy Clin Immunol. 2007;120:64–68
  38. Rogers AJ, Celedon JC, Lasky-Su JA, Weiss ST, Raby BA. Filaggrin mutations confer susceptibility to atopic dermatitis but not asthma. J Allergy Clin Immunol. 2007;120:1332–1337
  39. Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, DeBenedetto A, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol. 2007;120:150–155
  40. Santos daCosta JC, Olsen PC, Siqueira RA, Carvalho VF, Serra MF, Alves LA, et al. JMF2-1, a lidocaine derivative acting on airways spasm and lung allergic inflammation in rats. J Allergy Clin Immunol. 2007;119:219–225
  41. Buckland KF, O'Connor EC, Coleman EM, Lira SA, Lukacs NW, Hogaboam CM. Remission of chronic fungal asthma in the absence of CCR8. J Allergy Clin Immunol. 2007;119:997–1004
  42. Lerch M, Keller M, Britschgi M, Kanny G, Tache V, Schmmidt DA, et al. Cross-reactivity patterns of T cells specific for iodinated contrast media. J Allergy Clin Immunol. 2007;119:1529–1536
  43. Wu Y, Farrell J, Pirmohamed M, Park K, Naisbitt DJ. Generation and characterization of antigen-specific CD4+, CD8+ and CD4+CD8+ T-cell clones from patients with carbamazepine hypersensitivity. J Allergy Clin Immunol. 2007;119:973–981
  44. Loza MJ, Peters SP, Foster S, Khan IU, Penn RB. B-agonist enhances type 2 T-cell accumulation. J Allergy Clin Immunol. 2007;119:235–244
  45. Woods RA, Setse R, Halsey N. Irritant skin tests to common vaccines. J Allergy Clin Immunol. 2007;120:478–481
  46. Guarino MD, Perricone C, Guarino S, Garmbardello S, Dapice MR, Fontana L, et al. Denaturing HPLC in laboratory diagnosis of hereditary angioedema. J Allergy Clin Immunol. 2007;120:962–966
  47. Martin L, Raison-Peyron N, Nothe MM, Cichon S, Drouet C. Hereditary angioedema with normal C1 inhibitor gene in a family with affected women and men is associated with the p.Thr328Lys mutation in the F12 gene. J Allergy Clin Immunol. 2007;120:975–978
  48. Sloane DE, Lee CW, Sheffer AL. Hereditary angioedema: safety of long-term stanozolol therapy. J Allergy Clin Immunol. 2007;120:654–658
  49. Farkas H, Jakab L, Temesszentandrasi G, Visy B, Harmat G, Fust G, et al. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy. J Allergy Clin Immunol. 2007;120:914–917
  50. Schneider L, Lumry W, Vegh A, Williams AH, Schmalbach T. Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitor. J Allergy Clin Immunol. 2007;120:416–422
  51. Bohm A, Fodinger M, Wimazal F, Haas OA, Mayerhofer M, Sperr WR, et al. Eosinophilia in systemic mastocytosis: clinical and molecular correlates and prognostic significance. J Allergy Clin Immunol. 2007;120:192–199
  52. Maric I, Robyn J, Metcalfe DD, Fay MP, Carter M, Wilson T, et al. KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1/PDGFRA-associated chronic eosinophilia leukemia are distinct entities. J Allergy Clin Immunol. 2007;120:680–687
  53. Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007;357:1608–1619
  54. Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007;448:1058–1062
  55. Simon HU, Seger R. Hyper IgE syndrome associated with an IL-4 producing γδ+ T-cell clone. J Allergy Clin Immunol. 2007;119:246–248
  56. Freeman AF, Kleiner DE, Nadiminti H, Davis J, Quezado M, Anderson V, et al. Causes of death in Hyper IgE syndrome. J Allergy Clin Immunol. 2007;119:1234–1240
  57. Caudy AA, Reddy ST, Chatila T, Atkinson JP, Verbsky JW. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J Allergy Clin Immunol. 2007;119:482–487
  58. Sanka M, Tangsinmankong N, Loscalzo M, Sleasman JW, Dorsey MJ. Complete Digeorge syndrome associated with CHD7 mutation. J Allergy Clin Immunol. 2007;120:952–954
  59. McDonald DR, Mooster JL, Reddy M, Bawle E, Secord E, Geha RS. Heterozygous N-terminal deletion of IkBα results in functional nuclear factor κB haploinsufficiency, ectodermal dysplasia, and immune deficiency. J Allergy Clin Immunol. 2007;120:900–907
  60. French AR, Kim S, Fehniger TA, Pratt JR, Yang L, Song YJ, et al. Chronic lymphocytosis of functionally immature natural killer cells. J Allergy Clin Immunol. 2007;120:924–931
  61. Lavine E, Somech R, Zhang JY, Puel A, Boussyt X, Picard C, et al. Cellular and humoral aberration in a kindred with IL-1 receptor associated kinase 4 deficiency. J Allergy Clin Immunol. 2007;120:948–950
  62. Howell MD, Streib JE, Leung DY. Antiviral activity of human defensins 3 against vaccinia virus. J Allergy Clin Immunol. 2007;119:1022–1025
  63. Kim BE, Leung DY, Streib JE, Boguniewicz M, Hamid QA, Howell MD. Macrophage inflammatory protein 3 alpha deficiency in atopic dermatitis skin and role in innate immune response to vaccinia virus. J Allergy Clin Immunol. 2007;119:457–463
  64. Aspalter RM, Eibl MM, Wolff HM. Defective T cell activation caused by impairment of the TNF receptor 2 costimulatory pathway in common variable immunodeficiency. J Allergy Clin Immunol. 2007;120:1193–1200
  65. Zhang L, Radigan L, Salzer U, Behrens TW, Grimbacher B, Diaz G, et al. Transmembrane activation and calcium modulation cyclophylin ligand interactor mutations in common variable immunodeficiency: clinical and immunological outcomes in heterozygous. J Allergy Clin Immunol. 2007;120:1178–1185
  66. Castigli E, Wilson SA, Elkhal A, Ozcan E, Garibyan L, Geha RS. Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation. J Allergy Clin Immunol. 2007;120:885–891
  67. Moschese V, Carsetti R, Graziani S, Chini L, Soresini AR, LaRosa A, et al. Memory B-cell subsets as a predictive marker of outcome in hypogammaglobulinemia during infancy. J Allergy Clin Immunol. 2007;120:474–476
  68. Land MH, Garcia-Lloret MI, Bortzy MS, Rao PN, Aziz N, McGhee SA, et al. Long-term results of bone marrow transplantation in complete DiGeorge syndrome. J Allergy Clin Immunol. 2007;120:908–915
  69. Mazzolari E, Forino C, Guerci S, Imberti L, Lanfranchi A, Porta F, et al. Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency. J Allergy Clin Immunol. 2007;120:892–899
  70. Heltzer ML, Paessler M, Raffini L, Bunin N, Perez EE. Successful haploidentical bone marrow transplantation in a patient with reticular dysgenesis: three year follow up. J Allergy Clin Immunol. 2007;120:950–952
  71. Palmer K, Green TD, Roberts JL, Sajaroff E, Cooney M, Parrott R, et al. Unusual clinical and immunologic manifestations of transplacentally acquired maternal T cell in severe combined immunodeficiency. J Allergy Clin Immunol. 2007;120:423–428
  72. Shearer WT, Pahwa S, Read JS, Chen J, Wijayawardama S, Palumbo P. CD4/CD8 ratio predicts infection in HIV infants: the National Heart, Lung and Blood Institute P2C2 study. J Allergy Clin Immunol. 2007;120:1449–1452
  73. Pahwa S, Maresan P, Sleasman J, Fenton T, Moye J, Deveukis A, et al. Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric HIV patients with moderate immunosuppression: results of the Pediatric AIDS Clinical Trial Study 402. J Allergy Clin Immunol. 2007;119:1538–1542
  74. Gordon SB, Kaythy H, Molyneux , Haikala R, Nurkka A, Musaya J, et al. Pneumococcal conjugate vaccine is immunogenic in lung fluid of HIV infected and immunocompetent adults. J Allergy Clin Immunol. 2007;120:208–211
  75. Fletcher CV, DeVille JG, Samson PM, Moye JH, Church JA, Spiegel HML, et al. Non-linear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2 (PRO542) observed in HIV-infected children. J Allergy Clin Immunol. 2007;119:747–751
  76. Foster SB, Paul ME, Kozinetz CA, Macias CG, Shearer WT. Prevalence of asthma in young adults with HIV infection. J Allergy Clin Immunol. 2007;119:750–752

 Supported by National Institutes of Health Grants AI27551, AI069441, HD41983, HD052102, RR0188, HL079533, HL72705, HL78522, and RAT003084A and contract AI41089; the Pediatric Research and Education Fund, Baylor College of Medicine; and the David Fund, the Pediatrics AIDS Fund, and the Immunology Research Fund, Texas Children's Hospital.

 Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.

PII: S0091-6749(08)00779-3

doi: 10.1016/j.jaci.2008.04.035

The Journal of Allergy and Clinical Immunology
Volume 122, Issue 1 , Pages 36-41 , July 2008

Article Tools

* Image Usage & Resolution